Corona Outbreak

Covaxin, the COVID vaccine candidate by Hyderabad-based vaccine manufacturer Bharat Biotech Limited, being developed in collaboration with the Indian Council of Medical Research (ICMR), is likely to be available for use of the general…

The Government on Tuesday informed that470 new positive cases of novel Corona virus (COVID-19), 277 from Jammu division and 193 from Kashmir division, have been reported today thus taking the total number of positive cases in Jammu and…

Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield."As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the…

The SRM Medical College Hospital and Research Centre here on Monday announced the launch of the third phase of human trials for Covaxin - a vaccine for Covid-19 developed by Bharat Biotech.In a statement issued here, the SRM Medical College…

The Government on Sunday informed that 531 new positive cases of novel Corona virus (COVID-19), 308 from Jammu division and 223 from Kashmir division, have been reported today thus taking the total number of positive cases in Jammu and…

Coronavirus vaccination has kicked off in Moscow for at-risk groups including medical, educational and social workers, the city's coronavirus monitoring centre said on Saturday."Coronavirus vaccination began today at 70 city public health…

With the Union government focusing on early availability of coronavirus vaccine, experts on Saturday stressed that India should immediately scale up syringe supplies to deal with the vast number of inoculations required to control the…

Hours after Haryana Health Minister Anil Vij, who was administered a dose of Covaxin last month, tested positive for Covid-19, the city-based Bharat Biotech said that the efficacy of its Covid-19 vaccine could be determined only fourteen…

Researchers have discovered that the treatment of SARS-CoV-2 infection (Covid-19) with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.According to the study, published…

The chief advisor of the US Covid-19 vaccine development programme is confident that at least 100 million people would have got coronavirus shots by the end of February 2021 and this operation would have covered the entire "at risk"…